Ingredient
Methyl Perfluoroisobutyl Ether
Methyl Perfluoroisobutyl Ether is flagged for pregnancy, breastfeeding, trying to conceive, postpartum, PCOS and general use. The concern behind the strongest flag is absorbed into the body and fetal development.
- Perfluoromethylisopropyl Ether
- PFMIE
Verdict by profile
Truva checks every ingredient against six profiles. Jump to any of them for the full assessment.
- Strongest verdict
- Not Recommended
- Its verdict for pregnancy, the profile this one is worst in
- Profiles flagged
- 6 of 6
- Counting avoid, high risk and medium risk
- Irritancy
- 1 of 5
- Higher means more likely to sting or redden
Methyl Perfluoroisobutyl Ether and pregnancy
Not Recommended
- Absorbed into the body
- Fetal development
This ingredient is a perfluorinated compound (PFAS), a class of synthetic chemicals used as solvents in cosmetics. PFAS are valued for their unique chemical properties but have become controversial due to their environmental persistence and potential to accumulate in biological systems. While specific pregnancy studies on this exact compound are lacking, research on related PFAS compounds has raised significant concerns. Studies published in environmental health journals have found associations between maternal PFAS exposure and adverse pregnancy outcomes including preterm birth, lower birth weight, and developmental effects. PFAS compounds can cross the placental barrier and have been detected in cord blood. The persistent nature of these chemicals means they can accumulate in maternal tissues throughout pregnancy. Given the structural similarity to other concerning PFAS compounds and the lack of safety data specific to pregnancy, many toxicologists and environmental health experts recommend avoiding products containing perfluorinated ingredients during pregnancy as a precautionary measure. The CDC's National Biomonitoring Program has flagged PFAS compounds as chemicals of concern for vulnerable populations including pregnant women.
Methyl Perfluoroisobutyl Ether and breastfeeding
Not Recommended
- Passes into breast milk
- Infant exposure
As a perfluorinated compound, this ingredient belongs to a class of chemicals that have demonstrated the ability to transfer into breast milk. PFAS compounds are lipophilic and persistent, meaning they can accumulate in maternal tissues and be excreted through breast milk over extended periods. Research published in Environmental Health Perspectives and other peer-reviewed journals has detected various PFAS compounds in human breast milk samples worldwide. Studies have shown that breastfed infants can be exposed to PFAS through maternal milk, with concerns about potential impacts on infant immune development and growth. The American Academy of Pediatrics notes that while breastfeeding benefits generally outweigh risks, minimizing exposure to persistent environmental chemicals is advisable. Most dermatologists and lactation consultants recommend avoiding cosmetic products containing PFAS compounds during breastfeeding due to the potential for transfer to infants and the lack of safety data. The persistent nature of these chemicals means they cannot be easily eliminated from the body, making prevention of exposure particularly important during lactation.
Methyl Perfluoroisobutyl Ether and postpartum
Caution Advised
- Environmental pollutant
For postpartum women who are not breastfeeding, the immediate infant exposure concern is eliminated, but perfluorinated compounds still raise questions due to their persistent nature and potential bioaccumulation. These chemicals can remain in the body for years after exposure. While the acute reproductive risks are lower when not pregnant or breastfeeding, many health-conscious consumers and dermatologists prefer to avoid PFAS compounds due to broader health and environmental concerns. The persistent nature of these chemicals means they can accumulate if you later decide to conceive again. Some women may prefer to minimize exposure during the postpartum recovery period as a general health precaution.
Methyl Perfluoroisobutyl Ether and trying to conceive
Not Recommended
- Builds up in tissue
- Fertility effects
Women trying to conceive should be particularly mindful of exposure to perfluorinated compounds due to their persistent nature and potential bioaccumulation. PFAS compounds can remain in the body for years, meaning exposure during the TTC period can result in body burden during early pregnancy when fetal development is most vulnerable. Some epidemiological research has explored potential associations between PFAS exposure and fertility outcomes, though results are mixed and causation is not definitively established. The precautionary principle suggests avoiding accumulation of persistent chemicals during the preconception period. Many reproductive endocrinologists recommend optimizing environmental exposures at least three months before attempting conception, which is the timeframe when eggs mature and are most susceptible to environmental influences.
Methyl Perfluoroisobutyl Ether and PCOS
Caution Advised
- Endocrine disruptor
Women with PCOS already face hormonal imbalances, making exposure to potential endocrine-disrupting chemicals a consideration. While specific studies on this exact compound and PCOS are lacking, research on related PFAS compounds has suggested potential effects on hormone regulation and metabolic function. Some epidemiological studies have explored associations between PFAS exposure and metabolic disorders, though direct causation has not been established. Given that PCOS involves insulin resistance and hormonal dysregulation, some endocrinologists recommend minimizing exposure to potential endocrine disruptors as part of a comprehensive health approach. The risk level for PCOS is rated as medium rather than high because the evidence for direct hormonal effects from topical cosmetic use is limited. However, women with PCOS who are actively managing their condition may choose to avoid PFAS-containing products as a precautionary measure, particularly if they are also trying to conceive.
Methyl Perfluoroisobutyl Ether and general use
Caution Advised
- Endocrine disruptor
- Environmental pollutant
For the general public, perfluorinated compounds raise concerns primarily related to environmental persistence and potential bioaccumulation. These chemicals are often called 'forever chemicals' because they do not break down in the environment and can accumulate in human tissues over time. The European Chemicals Agency (ECHA) has been evaluating PFAS compounds for potential restrictions in consumer products due to their persistence and potential health effects. While specific toxicity data for this exact compound in cosmetics is limited, the broader class of PFAS has been associated with various health concerns in epidemiological studies, including effects on immune function and cholesterol metabolism. Many consumers and environmental health advocates recommend avoiding PFAS ingredients as a precautionary measure. From a cosmetic perspective, there are effective alternative solvents and viscosity controllers that do not raise these environmental and bioaccumulation concerns. The ingredient provides functional benefits but is not essential for product efficacy.
Everything else flagged for the same profiles
Related ingredients
Ingredients suggested in place of Methyl Perfluoroisobutyl Ether, each one with its own page here.
Ingredients that raise the same concerns.
Where this came from
Truva summarises published guidance from bodies including ACOG, the FDA, the EU SCCS and the Cosmetic Ingredient Review. It has no access to your medical history and it is not a substitute for your doctor, dermatologist or midwife. These assessments have not been reviewed by a clinician, and nothing here is a diagnosis or a prescription. If you are pregnant, breastfeeding or being treated for PCOS, take the ingredient list to the person looking after you.
Assessment last pulled from the ingredient database on .
One ingredient is the easy case.
A label has thirty of them. Truva reads the whole list at once and answers for the profile you set: pregnancy, breastfeeding, postpartum, trying to conceive, PCOS, or general use.
Download on theApp Store